A Better Weigh Inc
Weight Loss
- Address
- 17054 Oak Park Ave Ste B, Tinley Park 60477
- Telehealth
- Not listed
- Medicare
- Not listed
- Medicaid
- Not listed
Last verified Oct 2026 Report a correction
Tirzepatide Providers in Illinois
46 listed in Illinois · Listings last verified October 2026 · How we vet listings
We list tirzepatide providers across Illinois, mainly in Chicago, Carbondale–Marion and Belleville–Metro East (46 in total). Tirzepatide is the medicine in Zepbound and Mounjaro. Most listings are medical weight loss clinics, plus some primary care and diabetes practices. Compare the listings below, then call the practice to ask about insurance, costs and new-patient openings.
Tirzepatide (Zepbound, Mounjaro) providers in Illinois are mostly medical weight loss clinics in the Chicago area, with a few in Carbondale–Marion and the Metro East. Our list includes only providers whose own website or Google listing names tirzepatide.
What it is
Tirzepatide is a once-weekly prescription shot made by Eli Lilly. It acts on two gut hormones, GIP and GLP-1, that help control appetite and blood sugar. It's sold under two brand names:
- Zepbound is approved for weight loss and keeping weight off. It's also approved to treat moderate to severe obstructive sleep apnea in adults with obesity [1].
- Mounjaro is approved for adults with type 2 diabetes [3].
Zepbound comes as a single-dose pen, a vial or a multi-dose KwikPen that holds 4 weekly doses. You start at 2.5 mg and go up by 2.5 mg at least every 4 weeks, to a maintenance dose of 5, 10 or 15 mg [1]. The label has a boxed warning about thyroid tumors seen in animal studies [1].
Who it's for
Zepbound is for adults with obesity, or with overweight plus at least one weight-related health problem, such as high blood pressure or high cholesterol. It's also for adults with obesity who have moderate to severe sleep apnea [1].
It's used along with a lower-calorie diet and more activity. Most people stay on it long term, because weight often returns after stopping.
Mounjaro is for adults with type 2 diabetes. If you have diabetes, your doctor will usually start there, since diabetes coverage is easier to get.
Tirzepatide isn't right for everyone. Tell your provider if you or a family member has had medullary thyroid cancer or MEN 2, or if you've had pancreatitis [1]. It isn't approved for people under 18 [1].
Cost and coverage
Commercial insurance. If your plan covers Zepbound pens, the savings card can bring your cost to as little as $25 a fill. It pays up to $100 a month and $1,300 a year [2]. Mounjaro's card works the same way, paying up to $150 a month for covered patients [3]. Both cards end December 31, 2026 [2][3].
Self-pay. Lilly sells the Zepbound KwikPen and vials for $299 a month at 2.5 mg and $399 at 5 mg. Higher doses are $449 a month if you refill within 45 days. If you wait longer, the price goes up to $499 for 7.5 mg and $699 for 10 to 15 mg [2].
Medicare. From July 1, 2026, through December 31, 2027, the Medicare GLP-1 Bridge covers the Zepbound KwikPen for $50 a month. Single-dose pens and vials aren't included. You need Part D coverage, prior approval and a qualifying BMI. If you have type 2 diabetes or moderate to severe sleep apnea, you're not eligible for the Bridge, but your Part D plan may cover tirzepatide [4].
Medicaid. States must cover these drugs for diabetes but can choose whether to cover them for weight loss [5].
For more, see our Zepbound savings guide, how Zepbound works and GLP-1 guides.
Chicago area
A Better Weigh Medical Weight Loss Center
Weight Loss
- Address
- 9717 S Western Ave, Chicago 60643
- Telehealth
- Not listed
- Medicare
- Not listed
- Medicaid
- Not listed
Last verified Oct 2026 Report a correction
Affiliate Medical and Wellness Center
Weight Loss
- Address
- 64 Orland Square Dr #12, Orland Park 60462
- Telehealth
- Not listed
- Medicare
- Not listed
- Medicaid
- Not listed
Last verified Oct 2026 Report a correction
Axiom Medical Wellness
Weight Loss
- Address
- 2272 95th St Ste 125, Naperville 60564
- Telehealth
- Offers telehealth
- Medicare
- Not listed
- Medicaid
- Not listed
Last verified Oct 2026 Report a correction
Darshan Patel, MD
Aayu Well Healthcare
Weight Loss
- Address
- 20330 N Deer Park Blvd Ste 130, Deer Park 60010
- Telehealth
- Practice offers telehealth
- Medicare
- Not listed
- Medicaid
- Not listed
Last verified Oct 2026 Report a correction
Defiant Health Spa
Weight Loss
- Address
- 5100 Lincoln Ave, Lisle 60532
- Telehealth
- Offers telehealth
- Medicare
- Not listed
- Medicaid
- Not listed
Last verified Oct 2026 Report a correction
Empower LowT and Weight Loss
Weight Loss
- Address
- 16604 107th Ave, Orland Park 60467
- Telehealth
- Not listed
- Medicare
- Not listed
- Medicaid
- Not listed
Last verified Oct 2026 Report a correction
Gurnee Weight Loss Center
Weight Loss
- Address
- 501 N Riverside Dr Ste 216, Gurnee 60031
- Telehealth
- Offers telehealth
- Medicare
- Not listed
- Medicaid
- Not listed
Last verified Oct 2026 Report a correction
Kinetix Medical Weight Loss and Wellness
Weight Loss
- Address
- 742 N Ada St #1S, Chicago 60642
- Telehealth
- Offers telehealth
- Medicare
- Not listed
- Medicaid
- Not listed
Last verified Oct 2026 Report a correction
Lyndsay T. Hoffman, FNP
Options Medical Weight Loss Clinic
Weight Loss
- Address
- 21 W Rand Rd, Arlington Heights 60004
- Telehealth
- Practice offers telehealth
- Medicare
- Not listed
- Medicaid
- Not listed
Last verified Oct 2026 Report a correction
Mona Lala, MD
Kinetix Medical Weight Loss and Wellness
Weight Loss
- Address
- 742 N Ada St, Chicago 60642
- Telehealth
- Practice offers telehealth
- Medicare
- Not listed
- Medicaid
- Not listed
Last verified Oct 2026 Report a correction
Moonshot Medical and Performance
Weight Loss
- Address
- 542 Busse Hwy, Park Ridge 60068
- Telehealth
- Not listed
- Medicare
- Not listed
- Medicaid
- Not listed
Last verified Oct 2026 Report a correction
Options Medical Weight Loss Clinic
Weight Loss
- Address
- 2960 Artesian Rd #144, Naperville 60564
- Telehealth
- Offers telehealth
- Medicare
- Not listed
- Medicaid
- Not listed
Last verified Oct 2026 Report a correction
Options Medical Weight Loss Clinic
Weight Loss
- Address
- 5116 W 95th St, Oak Lawn 60453
- Telehealth
- Offers telehealth
- Medicare
- Not listed
- Medicaid
- Not listed
Last verified Oct 2026 Report a correction
Options Medical Weight Loss Clinic
Weight Loss
- Address
- 14215 LaGrange Rd #124, Orland Park 60462
- Telehealth
- Offers telehealth
- Medicare
- Not listed
- Medicaid
- Not listed
Last verified Oct 2026 Report a correction
Options Medical Weight Loss Clinic
Weight Loss
- Address
- 21 W Rand Rd, Arlington Heights 60004
- Telehealth
- Offers telehealth
- Medicare
- Not listed
- Medicaid
- Not listed
Last verified Oct 2026 Report a correction
Options Medical Weight Loss Clinic
Weight Loss
- Address
- 1440 Waukegan Rd, Glenview 60025
- Telehealth
- Offers telehealth
- Medicare
- Not listed
- Medicaid
- Not listed
Last verified Oct 2026 Report a correction
Options Medical Weight Loss Clinic
Weight Loss
- Address
- 3212 N Lincoln Ave, Chicago 60657
- Telehealth
- Offers telehealth
- Medicare
- Not listed
- Medicaid
- Not listed
Last verified Oct 2026 Report a correction
Peacock Health Collective
Weight Loss
- Address
- 954 W Washington Blvd, Chicago 60607
- Telehealth
- Offers telehealth
- Medicare
- Not listed
- Medicaid
- Not listed
Last verified Oct 2026 Report a correction
Physician Partners in Comp Weight Mgmt
Weight Loss
- Address
- 16W300 83rd St A, Burr Ridge 60527
- Telehealth
- Offers telehealth
- Medicare
- Not listed
- Medicaid
- Not listed
Last verified Oct 2026 Report a correction
How to choose a provider
Look for real medical care. A good provider reviews your health history, orders lab work when needed and checks in as your dose goes up. Ask who handles side effects like nausea, and how often you'll be seen.
Ask what they prescribe. Ask if they prescribe brand-name Zepbound or Mounjaro. Some businesses sell compounded "tirzepatide" instead. Compounded drugs are not FDA approved, and FDA has had reports of people hurt by dosing mistakes [6]. FDA declared the tirzepatide shortage over in December 2024 [7]. Our list doesn't include businesses that market compounded GLP-1s.
Ask about the paperwork. Ask if they'll handle prior approval with your insurer. If you have sleep apnea, ask whether they can document it. That's a separate approved use that some plans cover.
Confirm the basics yourself. Call to check insurance, new-patient openings and telehealth. We don't verify these.
Frequently asked questions
Are Zepbound and Mounjaro the same drug?
Yes. Both are tirzepatide, made by Eli Lilly, with the same dose steps. Zepbound is approved for weight loss and for sleep apnea in adults with obesity. Mounjaro is approved for type 2 diabetes. Because the approved uses differ, insurance plans cover them under different rules.
How much does Zepbound cost without insurance?
Lilly sells the Zepbound KwikPen and vials for $299 a month at 2.5 mg, $399 at 5 mg and $449 at higher doses if you refill within 45 days. If you refill later, higher doses cost $499 to $699 a month. Prices can change, so check Lilly's site before you fill.
Does Medicare cover Zepbound?
Often, yes. From July 2026 through December 2027, the Medicare GLP-1 Bridge covers the Zepbound KwikPen for $50 a month for eligible people with Part D. You need prior approval and a qualifying BMI. People with sleep apnea or type 2 diabetes go through their regular Part D plan instead.
Is compounded tirzepatide safe?
FDA says compounded drugs are not FDA approved, and the agency doesn't check them for safety, quality or effectiveness. FDA has received reports of people hospitalized after dosing errors. The tirzepatide shortage ended in December 2024, and brand-name Zepbound is now sold at self-pay prices.
How is tirzepatide taken?
Zepbound and Mounjaro are shots you give yourself under the skin once a week. You start at 2.5 mg for 4 weeks, then raise the dose by 2.5 mg no faster than every 4 weeks. For weight loss, the usual maintenance dose is 5, 10 or 15 mg. The KwikPen holds 4 weekly doses of one strength.
Sources
- DailyMed (NLM) — Zepbound (tirzepatide) prescribing information (rev. 8/2026)
- Lilly — Zepbound coverage, affordability and savings (self-pay KwikPen and vial pricing, savings card terms)
- Lilly — Mounjaro savings card terms
- Medicare.gov — Weight loss drugs (Medicare GLP-1 Bridge)
- KFF — Medicaid coverage of and spending on GLP-1s
- FDA — FDA's concerns with unapproved GLP-1 drugs used for weight loss
- FDA — FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize